TNFRSF4 and systemic lupus erythematosus: There was also no significant difference with respect to the percentages of IL-22-producing CD134+CD4+ T-cells in SLE patients without lupus nephritis as compared to HC (9.0 ± 8.4% vs. 19.0 ± 11.8%; p = 0.008).